Promising biomarkers for predicting the outcomes of patients withKRASwild-type metastatic colorectal cancer treated with anti-epidermal growth factor receptor monoclonal antibodies: A systematic review with meta-analysis-Reference-Cited by-同舟云学术

Promising biomarkers for predicting the outcomes of patients withKRASwild-type metastatic colorectal cancer treated with anti-epidermal growth factor receptor monoclonal antibodies: A systematic review with meta-analysis

Published:2013-07-13 Issue:8 Volume:133 Page:1914-1925
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Yang Zu-Yao,Wu Xin-Yin¹,Huang Ya-Fang¹,Di Meng-Yang¹,Zheng Da-Yong²,Chen Jin-Zhang²,Ding Hong³,Mao Chen,Tang Jin-Ling

Affiliation:

1. Division of Epidemiology, The Jockey Club School of Public Health and Primary Care; The Chinese University of Hong Kong; Hong Kong; China

2. Department of Oncology, Nanfang Hospital; Southern Medical University; Guangzhou; Guangdong Province; China

3. Department of Epidemiology, School of Public Health and Tropical Medicine; Southern Medical University; Guangzhou; Guangdong Province; China

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference51 articles.

1. GLOBOCAN Cancer fact sheet 2008 http://globocan.iarc.fr/factsheets/cancers/colorectal.asp#INCIDENCE1

2. Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials;Sargent;J Clin Oncol,2005

3. Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer;Bokemeyer;J Clin Oncol,2009

4. Monoclonal antibodies in the treatment of metastatic colorectal cancer: a review;Tol;Clin Ther,2010

5. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer;Cutsem;N Engl J Med,2009

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Approach to Colorectal Carcinoma;Clinics in Laboratory Medicine;2024-06

2. The histological and molecular characteristics of early-onset colorectal cancer: a systematic review and meta-analysis;Frontiers in Oncology;2024-04-26

3. Racial disparities in colorectal cancer clinicopathological and molecular tumor characteristics: a systematic review;Cancer Causes & Control;2023-09-09

4. CYP24A1, AHR, CPEB4, TRIP13, and PIK3CA genes expression in colorectal cancer patients: novel diagnostic biomarkers;EUR REV MED PHARMACO;2023

5. KRAS is a prognostic biomarker associated with diagnosis and treatment in multiple cancers;Frontiers in Genetics;2022-10-18